(Q35759166)

10 August 2017

The use of ciclosporin in psoriasis: a clinical review (English)

1 reference

10 August 2017

1 reference

Ho VC

1

1 reference

PubMed ID

15115440

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

British Journal of Dermatology

10 August 2017

1 reference

10 August 2017

150 Suppl 67

1 reference

10 August 2017

1-10

1 reference

Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.0366-077X.2004.05950.X

Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0366-077X.2004.05950.X

Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0366-077X.2004.05950.X

Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0366-077X.2004.05950.X

Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0366-077X.2004.05950.X

A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0366-077X.2004.05950.X

Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0366-077X.2004.05950.X

Adverse effects with long-term cyclosporin for severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0366-077X.2004.05950.X

Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0366-077X.2004.05950.X

Updates from the British Association of Dermatologists 83rd annual meeting, 1-4 July 2003, Brighton, U.K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0366-077X.2004.05950.X

10.1111/J.0366-077X.2004.05950.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15115440